Treating depression at home with transcranial direct current stimulation: a feasibility study
Katharina Dragon1, Mohamed A Abdelnaim1, Franziska C Weber1
1Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany.
Frontiers in Psychiatry
|March 19, 2024
Summary
Home-based transcranial direct current stimulation (tDCS) for major depressive disorder (MDD) showed minimal adverse events and positive usability. Further investigation is warranted for this convenient treatment option.
Area of Science:
- Neurology
- Psychiatry
- Biomedical Engineering
Background:
- Home-based transcranial direct current stimulation (tDCS) offers logistical advantages for treating major depressive disorder (MDD).
- Preliminary studies indicated potential challenges with home tDCS, including side effects and implementation difficulties, necessitating further feasibility research.
Purpose of the Study:
- To assess the feasibility, safety, and usability of home-based tDCS for patients with an acute depressive episode.
- To evaluate the effectiveness of home tDCS using standardized depression rating scales.
Main Methods:
- A one-arm feasibility study involving ten outpatients self-administering prefrontal tDCS at home for 30 days.
- Treatment implementation was verified via tDCS recordings, feasibility by compliance, effectiveness by HDRS-21, MDI, and DASS scores, and usability via UEQ.
- Adverse events (AEs) were systematically recorded to assess tolerability.
Main Results:
- Eight out of ten patients did not adhere to the full protocol.
- Adverse events were minimal, and four patients showed a positive response to home treatment based on the Major Depression Inventory (MDI).
- Patients reported positive usability of the home-based tDCS system.
Conclusions:
- Home-based tDCS appears safe and user-friendly in this feasibility study.
- Regular video consultations or alternative safety measures are recommended for home-based tDCS implementation.
- The findings support further investigation into home-based tDCS for major depressive disorder.


